ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Esophageal Achalasia

  • Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia
  • VZV in the Enteric Nervous System: Pathogenesis and Consequences
  • The Effect of Physiotherapy on Post POEM Reflux
  • Comprehensive Esophageal Diagnostics Study
  • Post Operative Pain Control of POEM Procedure
  • Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia
  • Ropivacaine For Post-POEM Pain Control
  • Botox or Botox With Esophageal Dilation in Patients With Achalasia
  • Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
  • Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia
  • Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia
  • Diagnostic Utility of Amyl Nitrite in Patients With Suspected Achalasia Undergoing High Resolution Esophageal Manometry (HREM)
  • Assessing the Efficacy of Steroid Treatment of Achalasia
  • Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia
  • vMII for Measurement of Oesophageal Bolus Transport and Reflux
  • Randomized Study of Botulinum Toxin Type A for Achalasia
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group